Biomarker ID | 550 |
PMID | 20957673 |
Year | 2011 |
Biomarker | Sarcosine |
Biomarker Basis | Expression Based |
Biomolecule | Metabolites |
Source | Urine |
Subjects | Humans |
Regulation | Differentially Expressed |
Odds Ratio/Hazard Ratio/Relative Risk | Univariate: OR: 1.034 (1.011 – 1.058); Multivariate: OR: 1.033 (95% CI: 1.001-1.065) |
Effect on Pathways | Pathways Include: Glycine, serine and threonine metabolism,Metabolism |
Experiment | Cancer Vs No Malignancy |
Type of Biomarker | Diagnostic |
Cohort | 86 untreated patients with CaP and 45 patients with no evidence of malignancy |
Senstivity | NA |
Specificity | NA |
AUC | 0.665 (95% CI: 0.571-0.759) |
Accuracy | NA |
Level Of Significance | Univariate: p=0.011; Multivariate: p=0.015 |
Method Used | Liquid Chromatography-Mass Spectrometry |
Clinical | No |
Remarks | NA |
Clinical Trial Number | NA |
Degree Of Validity | Not validated on independent patient dataset |
Technical Name | SARDH |